DTaP-hepatitis B vaccine - Kaketsuken/LG Chem

Drug Profile

DTaP-hepatitis B vaccine - Kaketsuken/LG Chem

Alternative Names: DTaP-HepB; Eutravac

Latest Information Update: 17 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kaketsuken; LG Life Sciences
  • Developer Kaketsuken; LG Chem
  • Class Bacterial vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 25 Jul 2013 Registered for Diphtheria in South Korea (Parenteral)
  • 25 Jul 2013 Registered for Hepatitis B in South Korea (Parenteral)
  • 25 Jul 2013 Registered for Pertussis in South Korea (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top